Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection

Jean-Benoit le Polain de Waroux; Sylvain Ploux; Pierre Mondoly; Romain Eschalier; Marc Strik; Laura Houard; Bertrand Pierre; Samuel Buliard; Nicolas Klotz; Philippe Ritter; Michel Haissaguerre; Karim Mahfouz; Pierre Bordachar

doi:10.1016/j.hrthm.2018.02.013

Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection

Jean-Benoit le Polain de Waroux^*, Sylvain Ploux, Pierre Mondoly, Romain Eschalier, Marc Strik, Laura Houard, Bertrand Pierre, Samuel Buliard, Nicolas Klotz, Philippe Ritter, Michel Haissaguerre, Karim Mahfouz, Pierre Bordachar

^*Corresponding author for this work

HV - Med.Staf-Artsass.Car

Research output: Contribution to journal › Article › Academic › peer-review

14 Citations (Web of Science)

Original language	English
Pages (from-to)	642-650
Number of pages	9
Journal	Heart Rhythm
Volume	15
Issue number	5
DOIs	https://doi.org/10.1016/j.hrthm.2018.02.013
Publication status	Published - 1 May 2018

Keywords

Complication
Defibrillation testing
Noise
Subcutaneous implantable cardioverter-defibrillator
Undersensing
RANDOMIZED-CONTROLLED-TRIAL
THERAPY
EXPERIENCE
EFFICACY
REGISTRY
SAFETY

Access to Document

10.1016/j.hrthm.2018.02.013Licence: Unspecified

Cite this

de Waroux, J-B. L. P., Ploux, S., Mondoly, P., Eschalier, R., Strik, M., Houard, L., Pierre, B., Buliard, S., Klotz, N., Ritter, P., Haissaguerre, M., Mahfouz, K., & Bordachar, P. (2018). Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection. Heart Rhythm, 15(5), 642-650. https://doi.org/10.1016/j.hrthm.2018.02.013

de Waroux, Jean-Benoit le Polain ; Ploux, Sylvain ; Mondoly, Pierre ; Eschalier, Romain ; Strik, Marc ; Houard, Laura ; Pierre, Bertrand ; Buliard, Samuel ; Klotz, Nicolas ; Ritter, Philippe ; Haissaguerre, Michel ; Mahfouz, Karim ; Bordachar, Pierre. / Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection. In: Heart Rhythm. 2018 ; Vol. 15, No. 5. pp. 642-650.

@article{fb5cd88eec4c48e6a895b96b8c771456,

title = "Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection",

keywords = "Complication, Defibrillation testing, Noise, Subcutaneous implantable cardioverter-defibrillator, Undersensing, RANDOMIZED-CONTROLLED-TRIAL, THERAPY, EXPERIENCE, EFFICACY, REGISTRY, SAFETY",

author = "{de Waroux}, {Jean-Benoit le Polain} and Sylvain Ploux and Pierre Mondoly and Romain Eschalier and Marc Strik and Laura Houard and Bertrand Pierre and Samuel Buliard and Nicolas Klotz and Philippe Ritter and Michel Haissaguerre and Karim Mahfouz and Pierre Bordachar",

year = "2018",

month = may,

day = "1",

doi = "10.1016/j.hrthm.2018.02.013",

language = "English",

volume = "15",

pages = "642--650",

journal = "Heart Rhythm",

issn = "1547-5271",

publisher = "Elsevier Science",

number = "5",

}

de Waroux, J-BLP, Ploux, S, Mondoly, P, Eschalier, R, Strik, M, Houard, L, Pierre, B, Buliard, S, Klotz, N, Ritter, P, Haissaguerre, M, Mahfouz, K & Bordachar, P 2018, 'Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection', Heart Rhythm, vol. 15, no. 5, pp. 642-650. https://doi.org/10.1016/j.hrthm.2018.02.013

Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection. / de Waroux, Jean-Benoit le Polain; Ploux, Sylvain; Mondoly, Pierre; Eschalier, Romain; Strik, Marc; Houard, Laura; Pierre, Bertrand; Buliard, Samuel; Klotz, Nicolas; Ritter, Philippe; Haissaguerre, Michel; Mahfouz, Karim; Bordachar, Pierre.

In: Heart Rhythm, Vol. 15, No. 5, 01.05.2018, p. 642-650.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection

AU - de Waroux, Jean-Benoit le Polain

AU - Ploux, Sylvain

AU - Mondoly, Pierre

AU - Eschalier, Romain

AU - Strik, Marc

AU - Houard, Laura

AU - Pierre, Bertrand

AU - Buliard, Samuel

AU - Klotz, Nicolas

AU - Ritter, Philippe

AU - Haissaguerre, Michel

AU - Mahfouz, Karim

AU - Bordachar, Pierre

PY - 2018/5/1

Y1 - 2018/5/1

KW - Complication

KW - Defibrillation testing

KW - Noise

KW - Subcutaneous implantable cardioverter-defibrillator

KW - Undersensing

KW - RANDOMIZED-CONTROLLED-TRIAL

KW - THERAPY

KW - EXPERIENCE

KW - EFFICACY

KW - REGISTRY

KW - SAFETY

U2 - 10.1016/j.hrthm.2018.02.013

DO - 10.1016/j.hrthm.2018.02.013

M3 - Article

C2 - 29709229

VL - 15

SP - 642

EP - 650

JO - Heart Rhythm

JF - Heart Rhythm

SN - 1547-5271

IS - 5

ER -